Please use this identifier to cite or link to this item:
Title: Polyethylene Glycol 35 as a Perfusate Additive for Mitochondrial and Glycocalyx Protection in HOPE Liver Preservation
Authors: Panisello Rosello, Arnau
Silva, Rui Teixeira da 
Castro, Carlos 
Bardallo, Raquel G.
Calvo, Maria
Folch-Puy, Emma
Carbonell, Teresa 
Palmeira, Carlos 
Roselló-Catafau, Joan 
Adam, René 
Keywords: polyethylene glycol 35 (PEG35); hydroxyethyl starch (HES); UW solution; IGL-1 solution; Belzer-MPS; HOPE; liver graft preservation
Issue Date: 9-Aug-2020
Publisher: MDPI
Serial title, monograph or event: International Journal of Molecular Sciences
Volume: 21
Issue: 16
Abstract: Organ transplantation is a multifactorial process in which proper graft preservation is a mandatory step for the success of the transplantation. Hypothermic preservation of abdominal organs is mostly based on the use of several commercial solutions, including UW, Celsior, HTK and IGL-1. The presence of the oncotic agents HES (in UW) and PEG35 (in IGL-1) characterize both solution compositions, while HTK and Celsior do not contain any type of oncotic agent. Polyethylene glycols (PEGs) are non-immunogenic, non-toxic and water-soluble polymers, which present a combination of properties of particular interest in the clinical context of ischemia-reperfusion injury (IRI): they limit edema and nitric oxide induction and modulate immunogenicity. Besides static cold storage (SCS), there are other strategies to preserve the organ, such as the use of machine perfusion (MP) in dynamic preservation strategies, which increase graft function and survival as compared to the conventional static hypothermic preservation. Here we report some considerations about using PEG35 as a component of perfusates for MP strategies (such as hypothermic oxygenated perfusion, HOPE) and its benefits for liver graft preservation. Improved liver preservation is closely related to mitochondria integrity, making this organelle a good target to increase graft viability, especially in marginal organs (e.g., steatotic livers). The final goal is to increase the pool of suitable organs, and thereby shorten patient waiting lists, a crucial problem in liver transplantation.
ISSN: 1422-0067
DOI: 10.3390/ijms21165703
Rights: openAccess
Appears in Collections:I&D CNC - Artigos em Revistas Internacionais

Show full item record


checked on Sep 1, 2023


checked on Sep 2, 2023

Page view(s)

checked on Sep 18, 2023


checked on Sep 18, 2023

Google ScholarTM




This item is licensed under a Creative Commons License Creative Commons